Atlas Trials

A Study of AL8326 in Non-Small Cell Lung Cancer

Clinical trial NCT06794957 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06794957
Sponsor
Advenchen Laboratories, LLC
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Non-small Cell Lung Cancer
Start date
2022-05-19
Primary completion
2027-12-01
Enrollment
158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.